- Nā lāʻau lapaʻau
- Nā Hōʻike Manaʻo
- ʻO ka Neuroblastoma
- Puʻupuʻu paʻa
- Nā Hōʻike Manaʻo
- TILS
- NK Cell Therapy
- ʻO ka Myasthenia Gravis (MG)
- ʻO ka maʻi leukemia lymphoblastic koʻikoʻi (B-ALL)
- ʻO ka Lupus Erythematosus Pūnaehana (SLE)
- ʻO ka maʻi leukemia lymphoblastic koʻikoʻi (T-ALL)
- ʻO ka Lymphoma Non-Hodgkin (NHL)
- ʻO ka Myeloma Nui (MM)
- ʻO ka Lymphom cell B nui e hoʻolaha ʻia
- ʻO ka maʻi leukemia lymphocytic B
- Myeloma
ʻO Mr. D----CanadianDiagnosis: Diffuse Large B-cell Lymphoma (DLBCL) me ka hoʻololi ʻana o TP53
ʻO mākou, ma ke ʻano he ʻoihana lapaʻau, ua loaʻa iā mākou ka hanohano e mālama i kahi maʻi i kapa ʻia ʻo Mr. D, nona mai Kanada mai. Ua ʻike ʻia ʻo ia me ka Diffuse Large B-cell Lymphoma (DLBCL) me kahi mutation TP53, kahi kūlana i hoʻokūkū nui i nā ʻano lapaʻau kuʻuna.
Ua hoʻomaka ʻo Mr. D i kāna huakaʻi e hakakā i kēia maʻi weliweli me ka manaʻolana a me ka hoʻoholo paʻa i hōʻike ʻia i kona ʻano. I ka wā mua, ua hana ʻo ia i ka chemotherapy R-CHOP laina mua, kahi hana lapaʻau maʻamau no DLBCL. ʻOiai nā manaʻolana mua, ua lilo nā hoʻāʻo ma hope me nā lāʻau lapaʻau laina lua e like me R-DHAP a me GEMOX-BTKi i mea ʻole, e waiho ana i kona kūlana i mea paʻakikī, i ka hoʻohoka nui ʻia o Mr. D a me kāna hui lapaʻau.
Ma ka ʻike ʻana i ka wikiwiki o ke kūlana a me ka pono no nā hoʻonā hou, ua hoʻoholo mākou e hoʻokomo iā Mr. D i loko o ka hoʻolālā lapaʻau CD19-CAR-T. Hoʻohana kēia ʻano hana hou loa i ka mālama ʻana i ka maʻi kanesa i ka mana o ka ʻōnaehana pale ponoʻī o ke kino e kuhikuhi a luku i nā hunaola kanesa, e hāʻawi ana i kahi kukuna o ka manaʻolana no nā maʻi e like me Mr. D i pau nā koho lapaʻau maʻamau.
ʻAʻole i emi iki ka kupaianaha o nā hopena. Hoʻokahi mahina ma hope o ka hoʻokomo ʻia ʻana o nā pūnaewele CD19-CAR-T, ua hoʻokō ʻo Mr. D i ke kala piha ʻana, kahi hana i manaʻo ʻia he hiki ʻole ke hoʻokō ʻia i nā pule wale nō ma mua. Eia naʻe, ʻaʻole i nele kēia huakaʻi i ke kala ʻana i kona mau pilikia. Ua loaʻa iā Mr. D ka cytokine release syndrome (CRS) a me ka grade 1 immune effector cell-associated neurotoxicity syndrome (ICANS) i ka wā o ka mālama ʻana. Mahalo, ua komo koke kā mākou hui lapaʻau makaʻala, e hoʻokele pono ana i kēia mau pilikia me ka tocilizumab, adalimumab, a me ka hormone therapy, e hōʻoiaʻiʻo ana i ka palekana a me ka ʻoluʻolu o Mr. D ma ke kaʻina hana.
ʻO ka pono o ka lāʻau lapaʻau CAR-T cell ma ka hihia o Mr. D he kukui ia o ka manaʻolana no nā poʻe maʻi DLBCL paʻakikī ma ka honua holoʻokoʻa, e hōʻike ana i ka hiki ke hoʻololi i kēia ʻano lapaʻau hou. Eia kekahi, hōʻike ka huakaʻi a Mr. D i ke kuleana koʻikoʻi o ka hana hui multidisciplinary a me ka mālama aloha i ke kaua ʻana i ka maʻi kanesa.
I ka noʻonoʻo ʻana i kona ʻike, ua hōʻike ʻo Mr. D i ka mahalo nui no ke kākoʻo kūpaʻa a me ka ʻike loea o kāna hui lapaʻau. "ʻO ke kiʻekiʻe o ka mālama a me ka hoʻolaʻa aʻu i loaʻa ai i loko o kaʻu mālama ʻana he mea kupanaha ia," wahi āna. "ʻAʻole wale lākou i mālama i koʻu maʻi, akā ua mālama pū lākou i koʻu mau pono noʻonoʻo a me ka meaʻai, e hōʻoia ana ua kākoʻo ʻia au i kēlā me kēia ʻanuʻu o ke ala."
He hōʻike ka moʻolelo o Mr. D i ke kūpaʻa o ka ʻuhane kanaka a me nā holomua kupaianaha i hana ʻia ma ke kahua o ka oncology. Ke hoʻomau nei mākou i ka hoʻokuke ʻana i nā palena o ka hana hou lapaʻau, ke kūpaʻa nei mākou i ka hāʻawi ʻana i ka mālama pilikino a me ke aloha i kēlā me kēia maʻi e hilinaʻi mai ana iā mākou i ko lākou olakino a me ka pono.

I ka hoʻomaka ʻana o ka maʻi a hoʻokahi lā ma mua a hoʻokahi mahina ma hope o ka hoʻokomo ʻana.
wehewehe2
Submit An Free Inquiry
Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

